免疫力低下的患者可以自我保护以避免感染COVID-19的五种方法
Mayo Clinic在家人齐聚共度节假日之际,免疫力低下的患者务必采取额外的措施,保护自己免于罹患COVID-19(2019 冠状病毒病),这一点很重要。免疫系统受损的人患上COVID-19重症的风险更高。这些人包括癌症患者、接受了移植手术并正在服用免疫抑制药物的患者,以及感染艾滋病毒/艾滋病的晚期和未接受过治疗的患者。
在家人齐聚共度节假日之际,免疫力低下的患者务必采取额外的措施,保护自己免于罹患COVID-19(2019 冠状病毒病),这一点很重要。免疫系统受损的人患上COVID-19重症的风险更高。这些人包括癌症患者、接受了移植手术并正在服用免疫抑制药物的患者,以及感染艾滋病毒/艾滋病的晚期和未接受过治疗的患者。
مدينة روتشستر، ولاية مينيسوتا- بينما تتجمع العائلات لقضاء العطلات، من المهم للمرضى الذين يعانون من نقص المناعة اتخاذ خطوات إضافية للمساعدة في حماية أنفسهم من فيروس كورونا المستجد (كوفيد-19). الأشخاص المصابون بضعف في جهاز المناعة عرضة بشكل أكبر لخطر المرض الشديد جرَّاء فيروس كورونا المستجد (كوفيد-19
Conforme as famílias se reúnem para as festas de final de ano, é importante que os pacientes imunocomprometidos tomem medidas extras para ajudar a se proteger da COVID-19. Pessoas com o sistema imunológico enfraquecido correm maior risco de adoecer gravemente com a COVID-19.
Dada la proximidad de las reuniones familiares para celebrar las festividades, es importante que los pacientes con compromiso inmunitario tomen medidas adicionales para protegerse contra la COVID-19.
As families prepare to gather later this month for Thanksgiving, it is important for patients who are immunocompromised to take extra steps to protect themselves from becoming infected with COVID-19. People who are immunocompromised have weakened immune systems, which means they have a higher risk of becoming severely ill from COVID-19.
• People who are on dialysis or who have undergone kidney transplantation have immune system–related differences compared with people with normal kidney function, and these differences are further amplified by SARS-CoV-2 infection. • The findings may help explain why these individuals face a higher risk of dying from COVID-19. • Results from the study will be presented online at ASN Kidney Week 2021 November 4–November 7.
Today, the American Society of Nephrology (ASN) announced the Barbara T. Murphy Endowed Lectureship. Established by Verici Dx (LSE: VRCI), Renalytix (LSE RENX and Nasdaq RNLX), and the American Society of Transplantation (AST), the new lectureship will honor Dr. Murphy’s legacy as a leader in transplant immunology and medicine by recognizing advances in kidney transplantation.
New research presented this week at ACR Convergence, the American College of Rheumatology’s annual meeting, shows that people with systemic autoimmune diseases do as well after lung or heart-lung transplants as those without any systemic causes of end-stage lung disease.
A growing number of hospitals have implemented patient blood management programs to reduce unnecessary blood transfusions and costs. A study published in Mayo Clinic Proceedings finds that such a program can not only substantially reduce transfusion use, but also reduce length of hospital stays and in-hospital adverse outcomes.
Hassenfeld Children’s Hospital at NYU Langone and the NYU Langone Transplant Institute reached a historic, first-ever milestone when surgeons replaced the lungs of a 16-year-old girl with cystic fibrosis.
Registrations for the national organ transplant waiting list related to alcoholic hepatitis as well as the number of deceased donor liver transplants for the inflammatory liver condition rose significantly during the pandemic, Michigan Medicine researchers found.
Researchers report waiting list registrations and deceased donor liver transplants in the U.S. for alcoholic hepatitis, which can develop after a short period of alcohol misuse, increased during COVID-19, exceeding volumes forecasted by pre-COVID-19 trends, while trends for alcohol-related cirrhosis and non-alcohol-associated liver disease remained unchanged.
People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis of U.S. national data. Findings will be presented today at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
The first investigational transplantation of a genetically engineered, nonhuman kidney to a human body was recently completed at NYU Langone Health—marking a major step forward in potentially utilizing an alternative supply of organs for people facing life-threatening disease.
In a study of children on the U.S. kidney transplant list from 2008 to 2019, researchers found no racial and ethnic disparities regarding time on the waitlist until transplantation either before or after a 2014 policy change.
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Keck Medicine of USC treatment plan significantly reduces hospitalizations and deaths of liver and kidney transplant recipients with COVID-19
Clinical equations that estimate patients’ kidney function include an adjustment for Black race. This survey-based study found that U.S. transplant centers agree that this adjustment is unsatisfactory.
Cesarean birth rates are on the rise, and this is especially true for high-risk pregnant women who have undergone organ transplantation. While cesarean births account for 31% of all deliveries in the United States, the rate of cesarean births for pregnant people with kidney transplants is 62.6% and 44.6% for liver transplants.
Physicians recommend that patients with pulmonary hypertension avoid pregnancy, given the high risk of death for the mother and baby. However, Candice Cruise was unaware of her condition until she reached 21 weeks of pregnancy.
A recent study examined the spectrum of antibody responses—including IgG, IgM, and IgA antibodies—in kidney transplant recipients infected with the virus that causes COVID-19
In a study published today in the American Journal of Transplantation, Johns Hopkins Medicine researchers say that children between the ages of 12 and 18 who have received solid organ transplants appear to mount a more robust immune response than their adult counterparts after a standard two-dose vaccination regimen against SARS-CoV-2, the virus that causes COVID-19.
An analysis of national data shows that kidney transplant recipients and individuals with kidney failure face a high risk of dying from COVID-19.
Today, advocates of the American Society of Nephrology (ASN) and 19 other kidney health professional and patient organizations are meeting with their congressional delegations, calling on them to enact policies to improve kidney health
In a worldwide pediatric study, researchers from Children’s Hospital Los Angeles show the clear benefit of using living donor liver tissue for transplants.
People who have received organ transplants face an elevated risk of developing cancer, primarily due to immunosuppression from medications to prevent organ rejection, as well as underlying medical conditions.
The Society of Thoracic Surgeons is highlighting two particularly interesting stories from COVID survivors who were on ECMO for months, with one patient eventually underdoing a double lung transplantation.
As head of the transplant program, Dr. Jain will work with the hospital's more than 30 pediatric subspecialists.
糖尿病的治疗方式在过去十年来取得了长足进展。糖尿病是一种可能导致严重并发症的终身慢性疾病。尽管治疗方式有所进展,但许多糖尿病患者仍在与疾病作斗争。
خلال العقد الماضي أُحرِزَت العديد من التطورات في علاجات السكري. مرض السكري هو مرض مزمن مع احتمال حدوث مضاعفات كبيرة. وعلى الرغم من التطورات المحرزة، يعاني الكثيرون من مرضى السكري جرّاء إصابتهم بالمرض.
Muitos avanços foram feitos em relação aos tratamentos da diabetes ao longo da década passada. A diabetes é uma doença crônica com cuidados necessários por toda a vida, com potencial para complicações significativas. Apesar dos avanços, muitas pessoas com diabetes lutam contra a doença.
El tratamiento de la diabetes ha avanzado mucho en la última década. La diabetes es una enfermedad crónica que dura toda la vida y causa complicaciones importantes. Pese a los avances, muchas personas diabéticas tienen problemas.
After more than 50 days on advanced life support, a multi-disciplinary team at UC San Diego Health helps a patient who contracted COVID-19 become a candidate for a successful double lung transplant. The transplant surgery was the first in the region performed on a COVID-19 patient.
Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.
The FDA and CDC have just approved and recommended an additional dose of mRNA COVID-19 vaccines for moderately and severely immunocompromised people. Who should get it?
UC San Diego researchers develop a method to grow hematopoietic stem cells in culture, with clinical implications for bone marrow transplants and aging research.
Vaccination against SARS-CoV-2 substantially lowers the risks of "breakthrough" infections and death due to COVID-19 in adult organ transplant recipients, according to a pair of research letters in Transplantation, the official Journal of The Transplantation Society and the International Liver Transplantation Society. The journal is published in the Lippincott portfolio by Wolters Kluwer.
The study enrolled 120 transplant patients between May 25th and June 3rd. None of them had COVID previously and all of them had received two doses of the Moderna vaccine. Half of the participants received a third shot of the vaccine (at the 2-month mark after their second dose) and the other half received placebo. The primary outcome was based on antibody level greater than 100 U/ml against the spike protein of the virus. In the placebo group - after three doses (where the third dose was placebo), the response rate was only 18% whereas in the Moderna three-dose group, the response rate was 55%.
The study enrolled 120 transplant patients between May 25th and June 3rd. None of them had COVID previously and all of them had received two doses of the Moderna vaccine. Half of the participants received a third shot of the vaccine (at the 2-month mark after their second dose) and the other half received placebo. The primary outcome was based on antibody level greater than 100 U/ml against the spike protein of the virus. In the placebo group - after three doses (where the third dose was placebo), the response rate was only 18% whereas in the Moderna three-dose group, the response rate was 55%.
This spring, anesthesiologist Jennifer Cutler, MD, was looking forward to a weekend relaxing with her husband and two teenaged children when she got the call – she was urgently needed to oversee anesthesiology for not one, but two, liver transplants at Cedars-Sinai.
A new study from Keck Medicine of USC reveals that Black recipients of liver transplants have lower post-transplant survival rates than white or Hispanic patients
UC San Diego researchers report that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.
One in four cancer patients lack sufficient immunity against measles and mumps, study finds
• After kidney transplantation, natural killer cells of the recipient become active because they miss “self” proteins on donor cells. • These cells contribute to organ rejection, in addition to traditional modes of rejection involving T cells and antibodies.
In support and in celebration of all organ donors who give the selfless gift of life and their recipients, Hackensack Meridian Hackensack University Medical Center is again proud to sponsor the Reimagined 2020 Donate Life Transplant Games, July 16 - 19, a biennial multi-sport festival recognizing the success of donation and transplantation.
The Vanderbilt Transplant Center performed a record number of solid organ transplants in fiscal year 2021 (FY 21) — 637 life-saving procedures among its adult and pediatric programs — despite occurring entirely during the COVID-19 pandemic.
Two of the leading names in health care in the tri-state region, New Jersey–based Atlantic Health System and New York–based NYU Langone Health, are teaming up to give patients greater access to heart and liver transplants and the coordinated, high-quality care needed to stay healthy. The clinical affiliation will partner NYU Langone’s nationally recognized transplant program with the nationally ranked Atlantic Health System Heart Care program located at Morristown Medical Center’s Gagnon Cardiovascular Institute (Morristown, NJ) and the ground-breaking liver services at Overlook Medical Center (Summit, NJ).
The lung transplant team at UC San Diego Health performed San Diego County’s first transplant surgery with lungs donated after cardiac death, an approach that could mean more opportunities to save the lives of those in critical need of new lungs.
Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney.